Global Hepatitis B Vaccines Business Research Report 2024: Market to Reach $3.9 Billion by 2030 from $2.9 Billion in 2023 with Combination Vaccines Accounting for $2.6 Billion
May 13, 2024 09:58 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Hepatitis B Vaccines Market...
Vaccines Market Experiences Surge with a Projected CAGR of 10.68% from 2023-2033 Amid Rising Infectious Diseases and Technological Advancements
February 07, 2024 10:27 ET
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccines Market Analysis & Forecast to 2023-2033: Market By Type; By Route of Administration; By Disease; By Age Group; By Distribution...
Recombinant Vaccines Research Report 2024: Market Poised for Accelerated Growth, Set to Reach $34.18 Billion by 2034 from $10.14 Billion in 2023
January 31, 2024 11:23 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
Inequitable Access Remains a Challenge in the HBV Vaccine Market Despite Increasing Healthcare Expenditure
November 10, 2023 08:38 ET
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Hepatitis B Virus (HBV) Vaccine Market (by End User, Composition, & Region): Insights and Forecast with Potential Impact of COVID-19...
Hepatitis B Vaccine (Recombinant) Market Size, Market Share, Data Analysis and Forecasts, 2023-2030 | Market Study by RationalStat
November 09, 2023 08:00 ET
|
Rationalstat LLC
Wilmington, Delaware, Nov. 09, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s most recent industry analysis, the Global Hepatitis B Vaccine (Recombinant) Market value is estimated at US$ 6.5...
Hepatitis B Vaccine Market Size To Surpass USD 12.36 Billion By 2030, exhibiting A CAGR Of 5.7%
July 17, 2023 07:06 ET
|
Fortune Business Insights
Pune, India, July 17, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, the global Hepatitis B Vaccine Market size was valued at USD 7.94 billion in 2022 and is projected to grow from...
Global Pediatric Vaccines Market 2023: Sector is Expected to Reach $65.4 Billion by 2030 at a CAGR of 5.9%
April 14, 2023 10:48 ET
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Vaccines Market, By Vaccine Type, By Technology, By Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity...
Pediatric Vaccine Global Market Research Report 2023
March 24, 2023 10:03 ET
|
Research and Markets
Dublin, March 24, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Vaccine Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global pediatric vaccine market is...
Global Hepatitis B Virus (HBV) Vaccine Market Report 2023-2027: Use of AI in Vaccine and Drug Design and Technological Advancements in Vaccine Administration Gaining Momentum
January 31, 2023 09:38 ET
|
Research and Markets
Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult & Pediatric), By Composition (Mono & Combination), By Region (The...
Hepatitis B Vaccine Market Size Worth USD 10.62 billion by 2029 | Report by Fortune Business Insight
January 10, 2023 06:55 ET
|
Fortune Business Insights
Pune, India, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The global hepatitis B vaccine market size was USD 7.53 billion in 2021. The market is projected to grow from USD 7.80 billion in 2022 to USD 10.62...